HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer

Clinical trial NCT00401427 · COMPLETED

Trial details

NCT number: NCT00401427
Sponsor: National Cancer Institute, Naples
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2002-11-01
Primary completion: 2006-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.